Skip to main content
Journal cover image

Edoxaban in the secondary prevention of VTE.

Publication ,  Journal Article
Levy, JH; Hunt, BJ
Published in: Lancet Haematol
May 2016

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet Haematol

DOI

EISSN

2352-3026

Publication Date

May 2016

Volume

3

Issue

5

Start / End Page

e208 / e209

Location

England

Related Subject Headings

  • Venous Thromboembolism
  • Thiazoles
  • Secondary Prevention
  • Pyridines
  • Humans
  • Anticoagulants
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., & Hunt, B. J. (2016). Edoxaban in the secondary prevention of VTE. Lancet Haematol, 3(5), e208–e209. https://doi.org/10.1016/S2352-3026(16)00037-5
Levy, Jerrold H., and Beverley J. Hunt. “Edoxaban in the secondary prevention of VTE.Lancet Haematol 3, no. 5 (May 2016): e208–9. https://doi.org/10.1016/S2352-3026(16)00037-5.
Levy JH, Hunt BJ. Edoxaban in the secondary prevention of VTE. Lancet Haematol. 2016 May;3(5):e208–9.
Levy, Jerrold H., and Beverley J. Hunt. “Edoxaban in the secondary prevention of VTE.Lancet Haematol, vol. 3, no. 5, May 2016, pp. e208–09. Pubmed, doi:10.1016/S2352-3026(16)00037-5.
Levy JH, Hunt BJ. Edoxaban in the secondary prevention of VTE. Lancet Haematol. 2016 May;3(5):e208–e209.
Journal cover image

Published In

Lancet Haematol

DOI

EISSN

2352-3026

Publication Date

May 2016

Volume

3

Issue

5

Start / End Page

e208 / e209

Location

England

Related Subject Headings

  • Venous Thromboembolism
  • Thiazoles
  • Secondary Prevention
  • Pyridines
  • Humans
  • Anticoagulants
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology